FDA NDC Directory · JSON-LD · Markdown

Lisdexamfetamine Dimesylate

NDC 0406-5128 · HUMAN PRESCRIPTION DRUG · TABLET, CHEWABLE

Labeler / ManufacturerSpecGx LLC
Marketing categoryAbbreviated NDA (generic) · App ANDA218850
Dosage form / routeTABLET, CHEWABLE · ORAL
Active ingredientsLISDEXAMFETAMINE DIMESYLATE (50 mg/1)
Marketing started20241217
Package count1

External sources

Source: openFDA. Public-domain (CC0).